Abstract The aim of the study is to compare the responsiveness of two joint inflammation scoring systems (dichotomous scoring (DS) versus semi-quantitative scoring (SQS)) using novel individualized ultrasound joint selection methods and existing ultrasound joint selection methods. Responsiveness measured by the standardized response means (SRMs) using the DS and the SQS system (for both the novel and existing ultrasound joint selection methods) was derived using the baseline and the 3-month total inflammatory scores from 20 rheumatoid arthritis patients. The relative SRM gain ratios (SRM-Gains) for both scoring system (DS and SQS) comparing the novel to the existing methods were computed. Both scoring systems (DS and SQS) demonstrated substantial SRM-Gains (ranged from 3.31 to 5.67 for the DS system and ranged from 1.82 to 3.26 for the SQS system). The SRMs using the novel methods ranged from 0.94 to 1.36 for the DS system and ranged from 0.89 to 1.11 for the SQS system. The SRMs using the existing methods ranged from 0.24 to 0.32 for the DS system and ranged from 0.34 to 0.49 for the SQS system. The DS system appears to achieve high responsiveness comparable to SQS for the novel individualized ultrasound joint selection methods.
Introduction
Musculoskeletal ultrasound is well suited as an outcome measure tool for rheumatoid arthritis (RA) joint assessment [1] . As demonstrated by two prospective multi-center RA studies [2, 3] , ultrasound synovitis dichotomous scoring (DS) and semiquantitative scoring (SQS) are at least as valid and reliable as clinical examination based on the Outcome Measures in Rheumatology (OMERACT) filter. SQS requires grading across multiple severity categories which may lead to greater scoring variability than DS (yes/no grading); DS has the advantage of being relatively quicker to perform. The acceptable performance metrics of these scores may depend on their application, either in clinical trials or everyday clinical care. It is therefore important to examine the relative performance metrics of both scoring methods, using a range of ultrasound scoring systems (that typically evaluate different joints). Recently, SQS assessment of joint synovitis, in combination with novel ultrasound joint selection methods, demonstrated superior sensitivity for detecting response to treatment when compared to existing methods. The improvement in sensitivity may be attributed to selection of a greater proportion of affected joints for subsequent scanning, using the novel methods, which maximized the potential for detecting improvement resulting in greater sensitivity for detecting change [4] . In this pilot study, our objective was to compare sensitivity of the DS and SQS joint inflammation scoring systems using novel and existing ultrasound joint selection methods.
Materials and methods
In this IRB approved study, seropositive RA subjects (DAS28 >3.2, ≥5 tender and/or swollen joints) initiating or up-titrating their disease-modifying anti-rheumatic drugs (DMARDs) and corticosteroid treatments were recruited and followed up prospectively. At baseline and 3 months, 44-joint clinical and ultrasound assessment data (on bilateral shoulders, hips, elbows, knees, ankles, mid-foot, wrists, and small joints of the hand and feet as previously described [4] ), were collected for analysis. Patients were recruited from March 2013 to April 2015 after providing informed consent.
Ultrasound and clinical joint assessment
Ultrasonography was performed using the Philips Medical Systems EPIQ 5G machine with a multi-frequency linear array transducer (5-17 MHz) or the General Electric Healthcare LOGIQe machine with a multi-frequency linear array transducer (5-13 MHz). The ultrasound settings were pre-set for the joints for each machine, and the same machine (and probe) was used for each patient throughout the study period. The ultrasound scans were acquired and scored by a rheumatologist (blinded to the joint assessor's clinical findings) experienced in musculoskeletal ultrasound. Clinical joint assessments were performed by either a study nurse or a metrologist. Standardized scanning based on the EULAR guidelines [5] was performed in the same outpatient location. Power Doppler (PD) vascularity and gray-scale synovial hypertrophy (GSSH) at the joints were scored using SQS or DS systems. The SQS system scores these inflammatory changes on a 0-3 severity scale using methods described previously [4] while the DS system scores the changes as yes (equivalent to SQS score of [1] [2] [3] or no (equivalent to SQS score of 0). Ultrasound tenosynovitis, clinical joint tenderness, and swelling were scored dichotomously in both systems. Joint pain was scored dichotomously with the DS system or semi-quantitatively (0-3 severity scale) with the SQS system.
Novel and existing methods
The novel and existing joint selection methods were previously described [4] and are summarized below. The novel methods include (i) the individualized utrasound method, which selects up to 7 or 12 ultrasonographically most inflamed joints, and (ii) the individualized compositeultrasound method, which utilizes both clinical joint symptoms and ultrasound joint findings to select up to 7 or 12 target joints. The existing methods include (a) a pre-specified 7-joint count [6] and (b) a 12-joint count derived from an ultrasound data reduction method [7] .
For individualized ultrasound and existing methods, the individual joint score (IJS) at each joint site was calculated as the sum of component ultrasound sub-scores divided by the maximum possible score at the joint. For individualized composite-ultrasound method, the IJS at each joint site was calculated as the sum of component ultrasound and clinical sub-scores divided by the maximum possible score at the joint. The IJSs were computed so as to equalize the score weights across the joints [4] .
The joint selection process using the novel methods follows an algorithm whereby the IJSs from 44 joint sites (including bilaterally the metacarpophalangeal joints 1 to 5, first interphalangeal joints, proximal interphalangeal joints 1 to 5, metatarsophalangeal joints 1 to 5, wrists, ankles, midtarsals, elbows, knees, shoulders, and hips) are ranked from the largest to the smallest. Joints with a larger IJS are selected first and the selection proceeds through a pre-determined joint sequence (e.g., from smaller joint sites then followed by medium joint sites and finally larger joint sites) [4] . Eventually, joints with lesser IJS will be selected until the target joint count (7 or 12) is reached. Therefore, the novel scoring methods enable selection of up to 7 or 12 most affected joint sites for subsequent scanning. The relevant IJSs from these joint sites are then further computed and analyzed as described in the BStatistical analysis^section below.
Statistical analysis
For the novel and existing methods, total inflammatory score (TIS) per patient was calculated as the sum of the IJSs at the relevant joint sites. Responsiveness at 3 months was measured using the standardized response mean (SRM). Mean TIS at 0 and 3 months was obtained and used to derive the SRM which was computed as the mean change in the TIS score divided by the standard deviation (SD) of the change in the TIS score. Threshold values from Cohen for the effect size (ES) are often used for interpreting the SRM [8] [9] [10] , i.e., ES < 0.20 is trivial; 0.20 ≤ ES < 0.50 is small; 0.50 ≤ ES < 0.80 is moderate; and ES ≥ 0.80 is large. Relative gains in SRM magnitude (SRMGains) at 3 months were reported comparing novel to existing methods using the 7 and 12 joint approaches (e.g., for both DS and SQS systems, the SRM-Gain for the individualized composite-ultrasound method using the 7 joint approach was calculated as the ratio of individualized composite-ultrasound method's SRM and existing method's SRM for the 7 joint approach).
Results

Patient baseline characteristics
Twenty RA subjects (mean age 57. 
DS and SQS systems
The mean (SD) total inflammatory scores of the DS and SQS systems (at baseline and 3 months) using the novel and existing methods are shown in Fig. 1 (via the 7 joint approach) and Fig. 2 (via the 12 joint approach) . The SRMs for both scoring systems were similar in magnitude for both individualized composite-ultrasound and individualized ultrasound methods, for both the 7 and 12 joint approaches.
For the 7 joint approach, both scoring systems when used with the novel methods (individualized composite-ultrasound and individualized ultrasound) showed higher SRMs (ranged from 0.94 to 1.36) when compared to existing methods (SRMs ranged from 0.24 to 0.34). The SRM-Gains ranged from 3.26 to 5.67.
For the 12 joint approach, both scoring systems when used with the novel methods (individualized composite-ultrasound and individualized ultrasound) also showed higher SRMs (ranged from 0.89 to 1.16) when compared to the SRMs of existing methods (ranged from 0.32 to 0.49). The SRM-Gains ranged from 1.82 to 3.63 (Table 1) .
Discussion
Our study is the first showing DS system can be highly sensitive to change, with a degree of responsiveness comparable to SQS system, using novel joint selection methods. In contrast, both scoring systems had the modest sensitivity to change using existing methods.
Three studies have compared DS and SQS quantifying ultrasound synovitis in RA patients [2, 3, 6] . DS versus SQS was compared in 68 RA patients using 20, 28, and 38 pre-fixed joints Fig. 1 Results of the dichotomous and semiquantitative scoring systems using the 7 joint approach. TIS total inflammatory score, DS dichotomous scoring, SQS semiquantitative scoring Fig. 2 Results of the dichotomous and semiquantitative scoring systems using the 12 joint approach. TIS total inflammatory score, DS dichotomous scoring, SQS semiquantitative scoring [2] . Intra-rater reliability was comparable between DS and SQS (with moderate to good intra-class correlation coefficient (ICC) ranging from 0.53 to 0.97). Another study involving 62 RA subjects also reported comparable ICC between DS and SQS (mean ICC for GS and PD ultrasound was 0.85 and 0.80, respectively) [3] . A third study, however, demonstrated higher intrarater reliability with DS (mean kappa 0.83) when compared to SQS (mean kappa 0.64) using four images with synovitis and erosions [6] . The inter-rater reliability was also higher for DS (kappa of 0.62 and 0.84 for GS and PD synovitis, respectively) when compared to SQS (kappa of 0.55 and 0.67 for GS and PD synovitis, respectively) using 33 ultrasound images. DS of ultrasound joint inflammation was found to correlate well with MRI findings in two studies [11, 12] demonstrating evidence of construct validity. In the first study involving 22 RA subjects, ultrasound joint inflammation scored dichotomously on the feet [11] had higher percentage exact agreement with MRI findings than clinical examination (63.6-77.3 versus 45.5-59.1 %, respectively). In the second study involving 12 RA subjects, ultrasound detected joint effusion and synovitis scored dichotomously at the finger joints had sensitivity and specificity of 0.83 and 0.94, respectively, when compared to MRI [12] .
DS may have lesser variability than SQS as demonstrated in one study showing higher intra-/inter-rater reliability [6] for DS. Additionally, DS may be logistically easier to implement in RA studies than SQS (e.g., easier to train personnel(s) in its use). However, there is less information on DS relative to SQS. Conceivably, DS may require a longer time interval than SQS before improvement in joint inflammation is detected.
Limitations of our study are the small sample size in this pilot study, the absence of reliability testing of DS versus SQS (although these were examined by previous studies), and evaluation of change using two time points. Future larger scale studies could assess change over multiple time points.
Overall, our study demonstrated high sensitivity to improvement using the DS system, which was shown to be comparable in sensitivity to the SQS system when used in combination with the novel individualized joint selection methods. If confirmed in larger RA cohorts, this would have important implications when choosing an ultrasound scoring system in future RA studies.
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